van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, et al. A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial. Dig Dis Sci 2024 Apr 9. doi: 10.1007/s10620-024-08410.
PMID: 38594435